Antivirals present ‘Pandora’s box’ of potential drug interactions

Hospital pharmacists warn of the need to support safe prescribing and dispensing of incoming novel oral COVID-19 treatments Leading hospital pharmacists are calling for a “consistent and streamlined” approach to support the safe prescribing and dispensing of novel oral COVID-19 treatments, with supplies of nirmatrelvir/ritonavir (Paxlovid) and molnupiravir (Lagevrio) due for imminent use in Australia.